Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo

NCT02192554 · clinicaltrials.gov ↗
COMPLETED
Status
450
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators